跳至主要内容
临床试验/CTRI/2025/08/093057
CTRI/2025/08/093057尚未招募2/3 期

Randomised controlled clinical trial to compare the efficacy of Bilwa Magaja Choorna with Nagakeshar Choorna in the management of Raktarsha

Tilak Ayurved Mahavidyalaya Pune1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年8月25日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
The use of Bilwa Magaja Choorna with Nagkeshar Choorna was effective in reducing Rakta Strava in Raktaarsha.

研究概览

简要总结

Objective

To evaluate and compare the clinical efficacy of Bilwa Magaja Choorna and Nagkeshar Choorna in treating Raktarsha (bleeding haemorrhoids), and to assess potential adverse effects

Background

Raktarsha, a form of Arsha (haemorrhoids), is a common anorectal disorder in Ayurveda, linked to poor diet, sedentary lifestyle, and Agnimandya (impaired digestion).

Modern surgical treatments often have complications; hence, the study seeks safer, cost-effective, Ayurvedic alternatives.

Hypothesis

Null Hypothesis Bilwa Magaja Choorna is as effective as Nagkeshar Choorna.

Alternative Hypothesis  Bilwa Magaja Choorna is more effective.

Methodology

Design: Open-label, randomized controlled clinical trial.

Participants: 70 patients (35 in each group) with 1st and 2nd degree Raktarsha.

Intervention

Group A (Trial): Bilwa Magaja Choorna (12 gm) with warm water.

Group B (Control): Nagkeshar Choorna (12 gm) with Navneet and Khadisakhar.

Duration: 14 days with follow-ups on Day 7 and Day 14.

Common Supportive Drug: Gandharva Haritaki Choorna (laxative).

Assessment Parameters

Subjective: Quantity of bleeding per anus.

Objective: Frequency of bleeding.

Investigations: Hb%, HIV, HBsAg.

Inclusion Criteria:

Age 18–60 years, 1st/2nd degree Raktarsha, Hb  less than 8 gm%.

Exclusion Criteria

3rd/4th degree haemorrhoids, Hb <8 gm%, pregnancy, HIV/HBsAg positive.

Analysis Tools:

Statistical Tests: Wilcoxon signed-rank test (subjective), t-test (objective).

Knowledge Gap & Rationale:

No prior comparative study on Bilwa Magaja Choorna alone.

Expected to be cost-effective, safe, and easy to administer.

Conclusion:

The study aims to establish Bilwa Magaja Choorna as a potentially more effective Ayurvedic treatment for Raktarsha compared to the standard Nagkeshar Choorna.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients having Raktarsha (1st degree,2nd degree) will be selected.
  • 2.Patient with Hb less than 8gm% 3.Patient of age between 18-60 years will be taken.
  • 4.Selected of patient will be done irrespective of sex, socioeconomic class, religion.

排除标准

  • 1.Known case of 3rd and 4th degree haemorrhoids 3rd Degree haemorrhoids- Piles prolapsed during defecation, can be replaced back only by manual help.
  • 4th Degree haemorrhoids- piles that are permanently prolapsed
  • Patients with Hb more than 8 gm%
  • Pregnancy
  • Known case of HIV, HBsAg excluded.

结局指标

主要结局

The use of Bilwa Magaja Choorna with Nagkeshar Choorna was effective in reducing Rakta Strava in Raktaarsha.

时间窗: 1st follow up on 7th day and then on 14th day

次要结局

  • Adverse drug reaction observed during treatment of Raktarsha with Bilwa magaja choorna(1st follow up on 7th day and then on 14th day)

研究者

发起方
Tilak Ayurved Mahavidyalaya Pune
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Shrikant Balaji Bhosale

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital

研究点 (1)

Loading locations...

相似试验